Variable frequency drives (VFDs) are used in many industrial applications to improve energy efficiency and provide precise ...

Alzheon’s con­tro­ver­sial, decade-long bet that a failed Alzheimer’s drug could of­fer big­ger ben­e­fits to a sub­set of pa­tients at the high­est risk for the dis­ease … ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

Qorvo 3-Phase BLDC Motor Driver Reduces Solution Size, Design Time and BOM Cost Qorvo, a global provider of connectivity and power solutions, has released the ACT72350—a 160V, 3-phase gate driver that ...

Phase 4 saw TV shows folded into the MCU's interconnected ... That will complete the second of the MCU's two Sagas to date, both of which contain three Phases. If this sounds like a lot, we ...

Three-time Speedway world champion Tai Woffinden has been airlifted to hospital following a "very serious" crash in Poland. The 34-year-old, Britain's most-decorated speedway racer, is understood ...

investigators deemed it unethical to include a placebo arm in the phase 3 study. Importantly, the study was funded by bentracimab developers PhaseBio Pharmaceuticals and SFJ Pharma, the latter of ...

Shortly after paying $800 million to take full control of BNT327, the biotech began a phase 3 trial to test the bispecific in combination with chemo in patients with previously untreated extensive ...

Nintendo’s upcoming Switch 2 release is stirring excitement with a unique three-phase game rollout strategy. Here’s what fans can expect from the console’s launch. By: HT TECH Nintendo Switch 2 is set ...

Turner (D-Ashburn) to include research into microgrids and other onsite power generation uses in its second phase of Comprehensive Plan and Zoning Ordinance amendments to data center regulations.

The XYNGARI™ Phase 3 Spongilla Treatment for Acne Research (STAR-1) trial met all three primary endpoints by achieving a statistically significant difference when compared with placebo after 12 weeks ...

A phase 3 trial will evaluate IMNN-001, the first immunotherapy to show an overall survival benefit in ovarian cancer. The FDA-aligned with a protocol to evaluate IMNN-001 with neoadjuvant ...